We use our own and third party cookies in order to improve our performance, and to obtain anonymous statistics about the use of the website. By continuing to browse, you authorize their use. In order to change the preferences and to obtain further information, please refer to our cookies policy.
The Immunology and Vaccines Business Unit is committed to fostering research and development into the discovery of vaccines and adjuvants capable of preventing and/or ameliorating immunolgical conditions that are rare, neglected, or othewise impact global health. Our research is focused on, but not limited to, leishmaniasis and other infectious, parasitic-born illnesses. Our goal is to ameliorate suffering. Our committment is complete.